Annovis Bio
Annovis Bio, Inc. is a clinical-stage biopharmaceutical company focused on developing therapies for neurodegenerative diseases. Their primary goal is to protect the brain and spinal cord from neurodegeneration, with a lead compound designed to address conditions like Alzheimer's and Parkinson's disease.
About Us
- Annovis Bio is a clinical-stage biopharmaceutical company dedicated to developing innovative treatments for debilitating neurodegenerative disorders such as Alzheimer's Disease (AD) and Parkinson's Disease (PD). - The company's lead drug candidate, Buntanetap (formerly ANVS401), is a small molecule designed to inhibit the production of neurotoxic proteins that accumulate in the brain and contribute to neuronal damage in these diseases. - By targeting a common neurotoxic pathway, Annovis Bio aims to restore axonal transport and synaptic function, thereby improving brain health and potentially modifying disease progression for patients with significant unmet medical needs.
Vision
To become a leading biopharmaceutical company in the treatment of neurodegenerative diseases by providing effective, disease-modifying therapies that can halt or reverse neuronal damage and significantly enhance patient quality of life.
Mission
To develop and bring to market novel therapeutic solutions that protect the brain and spinal cord from neurodegeneration, improving the lives of patients suffering from Alzheimer's, Parkinson's, and other related disorders.
Culture
- Annovis Bio fosters a research-driven and collaborative culture, characteristic of a clinical-stage biopharmaceutical company. - The team is dedicated to scientific rigor and innovation, focused on advancing their lead drug candidate through clinical trials. - Emphasizing patient impact, the company is committed to addressing the urgent need for effective treatments in neurodegenerative diseases through a lean and focused operational approach.
Specialties & Industries
Open Positions
No open positions at the moment
Check back later for new opportunities